Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
MAGNETIC RESONANCE TEXTURE ANALYSIS IS SUPERIOR TO MAGNETIZATION TRANSFER IMAGING FOR LONGITUDINAL ASSESSMENT OF FIBROSIS IN EXPERIMENTAL COLITIS
THE EFFECTS OF INFLAMMATORY BOWEL DISEASE ON CAREGIVERS: ABSENTEEISM AND JOB PRESENTEEISM. A SEGHNP MULTICENTER STUDY (SPANISH SOCIETY OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION)
CZECH EXPERIENCE WITH TREATMENT OF CROHN S DISEASE PERIANAL FISTULAS BY ALLOGENIC MESENCHYMAL STEM CELLS
COMPARATIVE OUTCOMES AND SAFETY OF BUDESONIDE-MMX VERSUS PREDNISOLONE FOR ULCERATIVE COLITIS AND POSSIBLE GENETICAL PREDICTORS OF SIDE-EFFECTS
DIAGNOSTIC DELAY AND ECONOMIC BURDEN IN IBD: A SINGLE-CENTRE EXPERIENCE IN PATIENTS TREATED WITH BIOLOGICS
LOW CONCENTRATION OF CITRATE IN AN ADALIMUMAB FORMULATION DOES NOT IMPACT THE INTENSITY OF INJECTION SITE PAIN: EVALUATION FOLLOWING A SINGLE DOSE OF GP2017, A LOW CONCENTRATION ADALIMUMAB BIOSIMILAR VERSUS HIGH CONCENTRATION ADALIMUMAB CITRATE-FREE FORMU
LOW DRUG LEVELS ARE IMMUNOGENIC:EXCESS INFLIXIMAB COMPETES WITH IFX/TNF COMPLEXES TO DECREASE COMPLEX-INDUCED IMMUNOGENICITY
CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS - A PROSPECTIVE OBSERVATIONAL STUDY
A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
OUTCOMES OF ANTI-TNF TREATMENT IN CROHN’S DISEASE: A REAL LIFE, TERTIARY CENTER EXPERIENCE
CHANGES IN QUALITY OF LIFE IN IBD PATIENTS DURING VEDOLIZUMAB THERAPY- RESULTS FROM THE PATIENT SUPPORT PROGRAM IN THREE REFERRAL CENTERS IN SERBIA
BURDEN OF BOWEL URGENCY ACROSS SPECIFIC TREATMENT GROUPS AMONG CROHN’S DISEASE PATIENTS – REAL WORLD GLOBAL STUDY ANALYSES
THE EFFECT OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKING AGENTS ON THE 5- AND 10-YEAR DISEASE COURSE OF CROHN’S DISEASE PATIENTS WITH HYPERTENSION
RISK FACTORS OF CYTOMEGALOVIRUS COLITIS IN INFLAMMATORY BOWEL DISEASE
OPTIMIZING DUAL-TARGETED THERAPIES IN INFLAMMATORY BOWEL DISEASE VIA MULTIPLE MECHANISMS OF ACTION
EFFICACY AND SAFETY OF USTEKINUMAB IN ASIAN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: A SUBPOPULATION ANALYSIS OF UNITI/IM-UNITI LONG-TERM EXTENSION THROUGH 5 YEARS
SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL
MRI EVOLUTION AND EFFICACY OF BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN PERIANAL FISTULAE IN CROHN’S DISEASE: RESULTS FROM A PROSPECTIVE MONOCENTRIC STUDY
SAFETY AND EFFICACY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CROHN’S DISEASE AFTER CYCLOPHOSPHAMIDE-FREE MOBILIZATION: PRELIMINARY RESULTS
THE CONTRIBUTION OF THE POLYMORPHISM OF THE ABCB1 GENE IN RESPONSE TO TREATMENT IN TUNISIAN INFLAMMATORY BOWEL DISEASE PATIENTS
Item 141 - 160 / 612
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Chat with us
, powered by
LiveChat